$18.57
0.02[0.11%]
Last update: 8:30AM Get Real Time Here
Kiniksa Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Kiniksa Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
07/23/2024 | AM | KNSA | Q2 | -$0.02 | — | — | — | $71.47M | — | — | — | Get Alert |
04/23/2024 | AM | KNSA | Q1 | -$0.18 | -$0.16 | -$0.25 | -56.25% | $48.34M | $78.46M | $79.86M | 1.78% | Get Alert |
02/28/2024 | AM | KNSA | Q4 | $0.06 | -$0.14 | $0.35 | 350.00% | $61.88M | $72.02M | $83.39M | 15.79% | Get Alert |
10/31/2023 | AM | KNSA | Q3 | $3.18 | -$0.17 | -$0.20 | -17.65% | $99.14M | $64.45M | $67.05M | 4.03% | Get Alert |
07/25/2023 | AM | KNSA | Q2 | -$0.29 | -$0.17 | -$0.02 | 88.24% | $26.97M | $52.20M | $71.47M | 36.92% | Get Alert |
05/02/2023 | AM | KNSA | Q1 | -$0.36 | -$0.21 | -$0.18 | 14.29% | $32.19M | $46.58M | $48.34M | 3.79% | Get Alert |
02/28/2023 | AM | KNSA | Q4 | -$0.53 | -$0.23 | $0.06 | 126.09% | $18.75M | $45.11M | $61.88M | 37.18% | Get Alert |
11/01/2022 | AM | KNSA | Q3 | -$0.44 | $0.50 | $3.18 | 536.00% | $12.10M | $74.39M | $99.14M | 33.26% | Get Alert |
08/03/2022 | AM | KNSA | Q2 | -$0.61 | -$0.44 | -$0.29 | 34.09% | $7.70M | $28.55M | $26.97M | -5.53% | Get Alert |
05/03/2022 | AM | KNSA | Q1 | -$0.72 | -$0.41 | -$0.36 | 12.20% | $0.00 | $22.77M | $32.19M | 41.37% | Get Alert |
02/22/2022 | AM | KNSA | Q4 | -$0.79 | -$0.42 | -$0.53 | -26.19% | $0.00 | $20.72M | $18.75M | -9.53% | Get Alert |
11/01/2021 | AM | KNSA | Q3 | -$0.66 | -$0.65 | -$0.44 | 32.31% | $0.00 | $10.18M | $12.10M | 18.81% | Get Alert |
08/03/2021 | AM | KNSA | Q2 | -$0.65 | -$0.79 | -$0.61 | 22.78% | $0.00 | $3.97M | $7.70M | 94.06% | Get Alert |
05/04/2021 | AM | KNSA | Q1 | -$0.48 | -$0.80 | -$0.72 | 10.00% | $0.00 | $3.72M | $0.00 | -100.00% | Get Alert |
02/23/2021 | AM | KNSA | Q4 | -$0.58 | — | -$0.79 | — | $0.00 | — | $0.00 | — | Get Alert |
11/05/2020 | AM | KNSA | Q3 | -$0.49 | — | -$0.66 | — | $0.00 | — | $0.00 | — | Get Alert |
07/30/2020 | AM | KNSA | Q2 | -$0.68 | — | -$0.65 | — | $0.00 | — | $0.00 | — | Get Alert |
04/28/2020 | AM | KNSA | Q1 | -$1.27 | -$0.63 | -$0.48 | 23.81% | $0.00 | — | $0.00 | — | Get Alert |
02/26/2020 | AM | KNSA | Q4 | -$0.88 | — | -$0.58 | — | $0.00 | — | $0.00 | — | Get Alert |
Kiniksa Pharmaceuticals (KNSA) is scheduled to report earnings on July 23, 2024. The last reported earnings were for reported on April 23, 2024 for Q1.
The Actual EPS was $-0.25, which missed the estimate of $-0.16.
The Actual Revenue was $79.9M, which beat the estimate of $78.5M.
Browse earnings estimates, EPS, and revenue on all stocks.